The Grove Bank & Trust Raises Position in Johnson & Johnson (JNJ)

The hedge fund held 62,191 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $8.09 million, down from 114,803 at the end of the previous reported quarter. Capital Counsel Llc who had been investing in Johnson & Johnson Com for a number of months, seems to be bullish on the $354.41 billion market cap company.

Shares of Johnson & Johnson (NYSE:JNJ) traded up $0.82 during trading hours on Wednesday, hitting $129.04.

Efficiency or profitability analysis gives an appropriate idea for investment decision; Johnson & Johnson (NYSE:JNJ) attains returns on investment ratio of 15.70%, which suggests it's viable on security that has lesser ROI. It has underperformed by 4.16% the S&P500.

Motco decreased its stake in Valero Energy New (VLO) by 89.39% based on its latest 2017Q3 regulatory filing with the SEC. The fund owned 100,711 shares of the company's stock after selling 11,640 shares during the quarter. The institutional investor held 65,420 shares of the packaged foods company at the end of 2017Q3, valued at $6.87 million, down from 71,520 at the end of the previous reported quarter. The stock increased 1.32% or $1.74 during the last trading session, reaching $133.8. After $1.60 actual earnings per share reported by United Technologies Corporation for the previous quarter, Wall Street now forecasts -5.63% negative EPS growth. Schlumberger Limited (NYSE:SLB) has declined 3.30% since March 11, 2017 and is downtrending. It has underperformed by 16.70% the S&P500. The firm has floated short ratio of 0.66%, hold to candle to sentiment indicator of Short Ratio, its stand at 2.28. Its the same as in 2017Q2. 59 funds opened positions while 158 raised stakes. Cardinal Cap holds 1.42% or 117,821 shares in its portfolio. BlackRock Inc. raised its stake in shares of Johnson & Johnson by 2.6% in the second quarter. Janney Montgomery Scott LLC grew its holdings in shares of Johnson & Johnson by 0.5% during the second quarter. 3,224 are held by Assetmark Inc. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: and their article: "What To Expect From Johnson & Johnson In 2018" published on March 06, 2018 as well as's news article titled: "At $128.22, Johnson & Johnson (JNJ) a Sell" with publication date: March 07, 2018. 4,485 are owned by Bradley Foster Sargent Incorporated Ct. Patten has invested 0.01% in Mohawk Industries, Inc. Northern Trust Corporation has invested 0.04% of its portfolio in The J.M. Smucker Company (NYSE:SJM). Farr Miller Washington Ltd Liability Corp Dc has 316,258 shares for 3.92% of their portfolio. Lpl Financial Lc owns 24,236 shares or 0.01% of their U.S. portfolio. Ltd. lifted its stake in shares of Johnson & Johnson by 29.9% in the 2nd quarter. Vaughan Nelson Inv Mgmt Limited Partnership stated it has 202,550 shares or 0.31% of all its holdings. Yandex N.V. (NASDAQ:YNDX) has risen 50.13% since March 8, 2017 and is uptrending. About 486,082 shares traded.

Among 9 analysts covering Yandex N.V. Zacks Investment Research downgraded shares of Johnson & Johnson from a "buy" rating to a "hold" rating in a research note on Tuesday, December 12th. Vetr has "Strong-Buy" rating and $106.73 target. Leerink Swann maintained it with "Buy" rating and $165.0 target in Wednesday, October 18 report. The stock of Johnson & Johnson (NYSE:JNJ) has "Underweight" rating given on Friday, July 21 by Alembic. The stock has a market capitalization of $353,330.00, a P/E ratio of 24.08, a P/E/G ratio of 2.10 and a beta of 0.77. The firm has "Hold" rating by Cowen & Co given on Monday, January 22. Longbow downgraded the stock to "Neutral" rating in Friday, August 28 report. BTIG Research reissued a "sell" rating and set a $110.00 price objective on shares of Johnson & Johnson in a report on Wednesday, January 24th. The company had revenue of $20.20 billion for the quarter, compared to analyst estimates of $20.08 billion. They expect $0.08 earnings per share, 0.00% or $0.00 from last year's $0.08 per share. SLB's profit will be $568.24M for 41.94 P/E if the $0.41 EPS becomes a reality. The company reported $1.74 EPS for the quarter, topping the Zacks' consensus estimate of $1.72 by $0.02.

Since February 15, 2018, it had 0 insider purchases, and 1 insider sale for $20.17 million activity. Da Davidson & invested in 379,199 shares or 0.86% of the stock. Balasa Dinverno & Foltz Ltd Liability Corp stated it has 0.59% of its portfolio in Johnson & Johnson (NYSE:JNJ). Mitsubishi Ufj Communications Limited owns 870 shares for 0.54% of their portfolio.

TRADEMARK VIOLATION NOTICE: "Johnson & Johnson (JNJ) Receiving Somewhat Positive Media Coverage, Accern Reports" was originally reported by BBNS and is the sole property of of BBNS. 52,940 were reported by Dean Ltd Liability Co. Winslow Evans & Crocker reported 0.72% in Johnson & Johnson (NYSE:JNJ). Focused Wealth Mgmt Inc owns 17,421 shares. Wealthtrust has invested 0.28% in Johnson & Johnson (NYSE:JNJ). 20,494 were accumulated by First Utd National Bank Trust. Georgia-based Smith And Howard Wealth Mngmt has invested 0.14% in Johnson & Johnson (NYSE:JNJ). 6,906 are held by Veritable L P. Transamerica Financial Advsr holds 0% or 4 shares.

PROMETIC LIFE SCIENCES ORDINARY SHARES (OTCMKTS:PFSCF) had a decrease of 16.8% in short interest. Ami Mngmt holds 1.78% or 11,530 shares. Hendershot Invests Inc, Virginia-based fund reported 38,300 shares. Therefore 67% are positive. Johnson & Johnson had 91 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of Johnson & Johnson (NYSE:JNJ) earned "Buy" rating by BMO Capital Markets on Thursday, October 5. RBC Capital Markets maintained it with "Buy" rating and $144.0 target in Friday, September 22 report.

A number of equities analysts recently weighed in on the stock. The firm has "Neutral" rating given on Tuesday, January 2 by JP Morgan. The rating was initiated by Societe Generale with "Hold" on Wednesday, April 6. RBC Capital Markets maintained it with "Buy" rating and $310.0 target in Tuesday, November 14 report.

Latest News